1(st) World Congress on Ga-68 and Peptide Receptor Radionuclide Therapy (PRRNT), June 23–26, 2011, Zentralklinik Bad Berka, Germany

por Baum, Richard P., Rösch, Frank
Publicado 2011

THERANOSTICS: From Molecular Imaging Using Ga-68 Labeled Tracers and PET/CT to Personalized Radionuclide Therapy - The Bad Berka Experience

por Baum, Richard P., Kulkarni, Harshad R.
Publicado 2012

The ICPO Foundation—on the way toward collaborative growth of theranostics

por Baum, Richard P., Mailman, Josh, Jaume, Odile
Publicado 2022

Efficacy of Detoxsan(®) powder on diarrhea caused by gastrointestinal neuroendocrine tumors

por Langbein, Thomas, Dathe, Wilfried, Deuerling, Anika, Baum, Richard P
Publicado 2019

Safety of High-Dose Botulinum Toxin Injections for Parotid and Submandibular Gland Radioprotection

por Mueller, Joerg, Langbein, Thomas, Mishra, Aditi, Baum, Richard P.
Publicado 2022

Metastatic extent predicts survival as patients with metastatic castration-resistant prostate cancer are treated with (177)Lu-PSMA radioligand therapy

por von Eyben, Finn Edler, Kulkarni, Harshad R., Baum, Richard P.
Publicado 2020

Handbook of nuclear medicine and molecular imaging: principles and clinical applications

por Kim, Edmund E, Lee, Dong-Soo, Tateishi, Ukihide, Baum, Richard P
Publicado 2012

[(68)Ga]Ga-DATA(5m)-LM4, a PET Radiotracer in the Diagnosis of SST(2)R-Positive Tumors: Preclinical and First Clinical Results

por Kanellopoulos, Panagiotis, Nock, Berthold A., Greifenstein, Lukas, Baum, Richard P., Roesch, Frank, Maina, Theodosia
Publicado 2022

Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with (177)Lu-PSMA and Combined (225)Ac- and (177)Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A S...

por Langbein, Thomas, Kulkarni, Harshad R., Schuchardt, Christiane, Mueller, Dirk, Volk, Gerd Fabian, Baum, Richard P.
Publicado 2022

Alpha-peptide receptor radionuclide therapy using actinium-225 labeled somatostatin receptor agonists and antagonists

por Shi, Mengqi, Jakobsson, Vivianne, Greifenstein, Lukas, Khong, Pek-Lan, Chen, Xiaoyuan, Baum, Richard P., Zhang, Jingjing
Publicado 2022

Different somatostatin and CXCR4 chemokine receptor expression in gastroenteropancreatic neuroendocrine neoplasms depending on their origin

por Mai, Rebekka, Kaemmerer, Daniel, Träger, Tina, Neubauer, Elisa, Sänger, Jörg, Baum, Richard P., Schulz, Stefan, Lupp, Amelie
Publicado 2019

Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms

por Kaemmerer, Daniel, Reimann, Christiane, Specht, Elisa, Wirtz, Ralph M., Sayeg, Manal, Baum, Richard P., Schulz, Stefan, Lupp, Amelie
Publicado 2014

From Automated Synthesis to In Vivo Application in Multiple Types of Cancer—Clinical Results with [(68)Ga]Ga-DATA(5m).SA.FAPi

por Greifenstein, Lukas, Kramer, Carsten S., Moon, Euy Sung, Rösch, Frank, Klega, Andre, Landvogt, Christian, Müller, Corinna, Baum, Richard P.
Publicado 2022

Nuclear medicine innovations help (drive) healthcare (benefits)

por Hacker, Marcus, Beyer, Thomas, Baum, Richard P., Kalemis, Antonis, Lammertsma, Adriaan A., Lewington, Val, Talbot, Jean-Noël, Verzijlbergen, Fred
Publicado 2014

PET image segmentation using a Gaussian mixture model and Markov random fields

por Layer, Thomas, Blaickner, Matthias, Knäusl, Barbara, Georg, Dietmar, Neuwirth, Johannes, Baum, Richard P, Schuchardt, Christiane, Wiessalla, Stefan, Matz, Gerald
Publicado 2015

Malignant presacral ghrelinoma with long-standing hyperghrelinaemia

por Falkmer, Ursula G., Gustafsson, Thomas, Wenzel, Ralf, Wierup, Nils, Sundler, Frank, Kulkarni, Harshad, Baum, Richard P., Falkmer, Sture E.
Publicado 2015

Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for (177)Lu-Labeled PSMA-Targeting Peptides

por Kletting, Peter, Schuchardt, Christiane, Kulkarni, Harshad R., Shahinfar, Mostafa, Singh, Aviral, Glatting, Gerhard, Baum, Richard P., Beer, Ambros J.
Publicado 2016

Novel Radiolabeled Bisphosphonates for PET Diagnosis and Endoradiotherapy of Bone Metastases

por Pfannkuchen, Nina, Meckel, Marian, Bergmann, Ralf, Bachmann, Michael, Bal, Chandrasekhar, Sathekge, Mike, Mohnike, Wolfgang, Baum, Richard P., Rösch, Frank
Publicado 2017

[(177)Lu-DOTA](0)-D-Phe(1)-Tyr(3)-Octreotide ((177)Lu-DOTATOC) For Peptide Receptor Radiotherapy in Patients with Advanced Neuroendocrine Tumours: A Phase-II Study

por Baum, Richard P., Kluge, Andreas W., Kulkarni, Harshad, Schorr-Neufing, Ulrike, Niepsch, Karin, Bitterlich, Norman, van Echteld, Cees J.A.
Publicado 2016

Case Report: Long-term complete response to PSMA-targeted radioligand therapy and abiraterone in a metastatic prostate cancer patient

por Parker, David, Zambelli, Jessica, Lara, Montana Kay, Wolf, Trevor Hamilton, McDonald, Amber, Lee, Erica, Abou-Elkacem, Lotfi, Gordon, Eva J., Baum, Richard P.
Publicado 2023